β-Galactosidase (40-1a) Antibody from Santa Cruz Biotechnology, Inc.

Yes, the β-Galactosidase (40-1a) antibody has been successfully utilized in Western blotting, as demonstrated in multiple studies, including those by Borgonetti et al. (borgonet2022, borgonet2023) and Jeong et al. (jeong2014), where it was employed to detect β-galactosidase in various experimental setups.

The β-Galactosidase antibody has been shown to work effectively in immunohistochemistry, as evidenced by its use in studies such as that by Laque et al. (laque2019), where it was applied to analyze brain sections for β-galactosidase expression.

This antibody is particularly useful for studying cellular senescence and neuroinflammation, as it has been shown to detect β-galactosidase expression in microglial cells, which are implicated in neuropathic pain and related comorbidities (borgonet2022, borgonet2023).

Yes, the β-Galactosidase antibody has been utilized in various animal models, including studies involving spared nerve injury in mice, where it helped assess the expression of senescence markers in microglia (borgonet2022, borgonet2023).